Drugs / Trivalent influenza vaccine-licensed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02035696 Comparator | Dec 2013 → Jun 2014 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent influenza vaccine-licensed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02035696 ↗ |
| Route | Intramuscular | “IM/0.25mL” NCT02035696 ↗ |